289 related articles for article (PubMed ID: 25651905)
1. Emerging biologics for the treatment of chronic rhinosinusitis.
Pauwels B; Jonstam K; Bachert C
Expert Rev Clin Immunol; 2015 Mar; 11(3):349-61. PubMed ID: 25651905
[TBL] [Abstract][Full Text] [Related]
2. [Progress of monoclonal antibody treatment for chronic rhinosinusitis with or without nasal polyps].
Chen YJ; Chai XB
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 May; 32(10):789-793. PubMed ID: 29873221
[TBL] [Abstract][Full Text] [Related]
3. Biotherapeutics in Chronic Rhinosinusitis with and without Nasal Polyps.
Bachert C; Gevaert P; Hellings P
J Allergy Clin Immunol Pract; 2017; 5(6):1512-1516. PubMed ID: 28526278
[TBL] [Abstract][Full Text] [Related]
4. Targeting IL-25 as a novel therapy in chronic rhinosinusitis with nasal polyps.
Lee M; Kim DW; Shin HW
Curr Opin Allergy Clin Immunol; 2017 Feb; 17(1):17-22. PubMed ID: 27870664
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibody therapy in sinonasal disease.
Chiarella SE; Sy H; Peters AT
Am J Rhinol Allergy; 2017 Mar; 31(2):93-95. PubMed ID: 28281440
[TBL] [Abstract][Full Text] [Related]
6. Chronic Rhinosinusitis-Could Phenotyping or Endotyping Aid Therapy?
Bayar Muluk N; Cingi C; Scadding GK; Scadding G
Am J Rhinol Allergy; 2019 Jan; 33(1):83-93. PubMed ID: 30353741
[TBL] [Abstract][Full Text] [Related]
7. Current and emerging biologic therapies for allergic rhinitis and chronic rhinosinusitis.
Licari A; Castagnoli R; De Filippo M; Foiadelli T; Tosca MA; Marseglia GL; Ciprandi G
Expert Opin Biol Ther; 2020 Jun; 20(6):609-619. PubMed ID: 32053391
[No Abstract] [Full Text] [Related]
8. Chinese Expert Consensus on the Use of Biologics in Patients with Chronic Rhinosinusitis (2022, Zhuhai).
Hong HY; Chen TY; Yang QT; Sun YQ; Chen FH; Lou HF; Wang HT; Yu RL; An YF; Liu F; Wang TS; Lu MP; Qiu QH; Wang XD; Chen JJ; Meng CD; Xie ZH; Meng J; Zeng M; Xu CL; Wang Y; Yang YC; Zhang WT; Tang J; Yang YL; Xu R; Yu GD; Shi ZH; Wei X; Ye HP; Sun YN; Yu SQ; Zhang TH; Yong J; Hang W; Xu YT; Xu Y; Tan GL; Sun N; Yang G; Li YJ; Ye J; Zuo KJ; Zhang LQ; Wang XY; Yang AN; Xu YX; Liao W; Fan YP; Li HB
ORL J Otorhinolaryngol Relat Spec; 2023; 85(3):128-140. PubMed ID: 37019094
[TBL] [Abstract][Full Text] [Related]
9. Biologic Agents for the Treatment of Chronic Rhinosinusitis With Nasal Polyps.
Kartush AG; Schumacher JK; Shah R; Patadia MO
Am J Rhinol Allergy; 2019 Mar; 33(2):203-211. PubMed ID: 30587005
[TBL] [Abstract][Full Text] [Related]
10. Improvement in Smell Using Monoclonal Antibodies Among Patients With Chronic Rhinosinusitis With Nasal Polyps: A Systematic Review.
Barroso B; Valverde-Monge M; Betancor D; Gómez-López A; Villalobos-Vilda C; González-Cano B; Sastre J
J Investig Allergol Clin Immunol; 2023 Dec; 33(6):419-430. PubMed ID: 37669083
[TBL] [Abstract][Full Text] [Related]
11. Chronic rhinosinusitis with nasal polyps: insights into mechanisms of disease from emerging biological therapies.
Kariyawasam HH
Expert Rev Clin Immunol; 2019 Jan; 15(1):59-71. PubMed ID: 30370785
[No Abstract] [Full Text] [Related]
12. A call for cost-effectiveness analysis for biologic therapies in chronic rhinosinusitis with nasal polyps.
Codispoti CD; Mahdavinia M
Ann Allergy Asthma Immunol; 2019 Sep; 123(3):232-239. PubMed ID: 31295554
[TBL] [Abstract][Full Text] [Related]
13. Biologics for chronic rhinosinusitis.
Chong LY; Piromchai P; Sharp S; Snidvongs K; Philpott C; Hopkins C; Burton MJ
Cochrane Database Syst Rev; 2020 Feb; 2(2):CD013513. PubMed ID: 32102112
[TBL] [Abstract][Full Text] [Related]
14. The Role of Biologics in the Treatment of Nasal Polyps.
Franzese CB
Immunol Allergy Clin North Am; 2020 May; 40(2):295-302. PubMed ID: 32278452
[TBL] [Abstract][Full Text] [Related]
15. Use of biologics in chronic sinusitis with nasal polyps.
Wang C; Zhang L
Curr Opin Allergy Clin Immunol; 2019 Aug; 19(4):365-372. PubMed ID: 31082822
[TBL] [Abstract][Full Text] [Related]
16. Phenotypes of Chronic Rhinosinusitis.
Cho SH; Hamilos DL; Han DH; Laidlaw TM
J Allergy Clin Immunol Pract; 2020 May; 8(5):1505-1511. PubMed ID: 32389275
[TBL] [Abstract][Full Text] [Related]
17. Pathogenesis-based application of biologics for chronic rhinosinusitis: Current and future perspectives.
Okano M; Kanai K; Oka A
Auris Nasus Larynx; 2024 Apr; 51(2):371-378. PubMed ID: 37743131
[TBL] [Abstract][Full Text] [Related]
18. Chronic rhinosinusitis management beyond intranasal steroids and saline solution irrigations.
Li N; Peters AT
Allergy Asthma Proc; 2015; 36(5):339-43. PubMed ID: 26314815
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and Safety of Dupilumab Versus Omalizumab in Chronic Rhinosinusitis With Nasal Polyps and Asthma: EVEREST Trial Design.
De Prado Gomez PharmD MSc L; Khan Mbbs Mph AH; Peters Md AT; Bachert Md PhD C; Wagenmann Md M; Heffler Md PhD E; Hopkins BMBCh C; Hellings Md PhD PW; Zhang PhD M; Xing PhD J; Rowe Md P; Jacob-Nara Md Mph DHSc JA
Am J Rhinol Allergy; 2022 Nov; 36(6):788-795. PubMed ID: 35837739
[TBL] [Abstract][Full Text] [Related]
20. An update on the role of chronic rhinosinusitis with nasal polyps as a co-morbidity in severe asthma.
Castagnoli R; Licari A; Brambilla I; Tosca M; Ciprandi G; Marseglia GL
Expert Rev Respir Med; 2020 Dec; 14(12):1197-1205. PubMed ID: 32875924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
